Maternal Body Mass Index and the Risk of Preeclampsia: A Systematic Overview
O’Brien, Tara E.; Ray, Joel G.; Chan, Wee-Shian
From the Division of Obstetrical Medicine, Department of Medicine, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario.
Tara O’Brien, Sunnybrook and Women’s College Health Sciences Centre, 76 Grenville Street, Toronto, Ontario, Canada, M5S 1B2; email@example.com.
Submitted 5 April 2002; final version accepted 21 January 2003.
Background. Maternal obesity, both in itself and as part of the insulin resistance syndrome, is an important risk factor for the development of preeclampsia. Accurately quantifying the relation between prepregnancy maternal body mass index and the risk of preeclampsia may better identify those at highest risk. We performed a systematic overview of the literature to determine the association between prepregnancy body mass index and the risk of preeclampsia.
Methods. Two reviewers independently retrieved all relevant English language cohort studies through a systematic search of Medline and Embase between 1980 and June 2002. Study data were abstracted in a similar fashion. For each study, the risk ratio of preeclampsia was calculated by comparing the risk of preeclampsia among women with the highest body mass index with those with the lowest.
Results. We identified thirteen cohort studies, comprising nearly 1.4 million women. The risk of preeclampsia typically doubled with each 5–7 kg/m2 increase in prepregnancy body mass index. This relation persisted in studies that excluded women with chronic hypertension, diabetes mellitus or multiple gestations, or after adjustment for other confounders.
Conclusions. Most observational studies demonstrate a consistently strong positive association between maternal prepregnancy body mass index and the risk of preeclampsia. Increasing obesity in developed countries is likely to increase the occurrence of preeclampsia. Consideration should be given to the potential benefits of prepregnancy weight reduction programs.
Preeclampsia is a multisystem disease affecting between 3% and 10% of pregnancies. 1 Little is still known about the pathogenesis of preeclampsia, making its prevention an ongoing challenge. 1,2 Maternal obesity and insulin resistance are believed to be important risk factors for the development of placental endothelial dysfunction and preeclampsia. 3,4,5 The dysmetabolic syndrome (“syndrome X”) is recognizable from the presence of obesity, hypertriglyceridemia, hyperglycemia, insulin resistance and hypertension, and is found among 7% of U.S. women of reproductive age. 6 Because an elevated body mass index (BMI; weight [kg] per height squared [m2]) is a major component of this syndrome, as well as an important risk factor for preeclampsia and other complications of pregnancy, 7 a more precise estimate of the association between maternal prepregnancy BMI and preeclampsia is needed.
We conducted a systematic overview of the association between prepregnancy BMI and preeclampsia, with two practical objectives. First, a clear summary of the association might allow better prediction of a woman’s risk of developing preeclampsia and, thus, improve clinical surveillance. Second, such a summary would be useful in predicting the possible benefits of prepregnancy weight reduction on the risk of preeclampsia.
Two investigators (T.O. and J.R.) independently searched Medline and Embase between 1980 and June 2002, using the following search terms: (“body mass index” or “obesity” or “fat” or “adiposity” or “overweight”) and (“preeclampsia” or “eclampsia” or “gestational hypertension” or “pregnancy-induced hypertension” or “toxemia”). References from review articles and research papers were also examined for other potentially eligible studies. We asked authors for additional information when data in their original publication were not sufficiently detailed. We included all English-language cohort studies that assessed the association between prepregnancy BMI as the primary exposure and preeclampsia and that included at least 50 participants. Data were independently abstracted by these two investigators, as outlined in Tables 1 and 2. We used the prepregnancy BMI categories as defined by the authors of each study, and the corresponding number of women with preeclampsia within each BMI category (Table 2).
For each study, we calculated an unadjusted risk ratio (RR) for preeclampsia, comparing each higher BMI category with the lowest category, which served as the referent. An unadjusted RR and its 95% confidence interval (CI) were plotted for each. Because of differences between studies in the defined BMI categories and in participant inclusion and exclusion criteria, we chose, a priori, not to pool the risk estimates. Because some studies adjusted for various sets of covariates using multiple logistic regression analysis, those results are presented separately (Table 3).
For the second study objective, we performed a separate analysis to estimate the degree of change in the risk of preeclampsia according to increasing BMI. We plotted the data from all studies on a single scattergraph and generated a straight line of best fit. The x-axis represented the mid-point of each BMI category, and the y-axis the corresponding risk of preeclampsia. For example, for a BMI category of 24 to 26 kg/m2, a mid-point value of 25 kg/m2 was chosen. When a BMI category was defined as being greater (or less) than a specific value, then a BMI value one decimal place higher (or lower) than that value was used. For example, if the highest BMI category was “≥30.0 kg/m2”, then a value of “30.1 kg/m2” was used, whereas a BMI category of “<20 kg/m2” was designated as “19.9 kg/m2.” The latter approach, though potentially imprecise, would enable an estimation of the relation between BMI and the risk of preeclampsia.
For the second analysis, the mean and CI change in the risk of preeclampsia for each kg/m2-unit change in BMI were approximated using a weighted mixed-effects linear model. This method, analogous to a combination of linear regression and analysis of variance (ANOVA), models a data set by both the mean (ie, fixed-effects) and variance-covariance (ie, random-effects) parameters (see Appendix). Including covariance estimates in the model acknowledges that the experimental units on which the data are measured units (ie, each individual BMI-preeclampsia category) are grouped into clusters (ie, individual studies), and that the data from a common cluster are correlated. An inverse-variance–weighted mixed-effects linear model was created, accounting for the different numbers of women within each BMI-preeclampsia category. To obtain appropriate interpretations of intercepts and slopes, the BMI was centered to the study’s mean levels. Statistical significance testing was set at a 2-sided P-value less than 0.05. Mixed linear modeling was done using the MIXED Procedure in SAS Version 8 (SAS Institute Inc., Cary, North Carolina), whereas Meta-Analyst 0.988 (Lau J. Meta-Analyst 0.988. Boston: Meta-Analyst Statistical Software, 1995) and Microsoft Excel version 5.0c (Microsoft Corporation, 1985–1994) were used to generate the Figures.
The initial searches of Medline and Embase yielded 491 and 125 citations, respectively. Of the 13 studies that met the inclusion criteria, eight originated from the United States 8–15 and the remainder were from Sweden, 16 the Netherlands, 17 Latin and Caribbean Amer-ica, 18 Taiwan 19 and the United Kingdom (Table 1). 20 Five of the studies excluded women with chronic hypertension, 9,12,13,17,19 four excluded women with diabetes mellitus, 9,12,13,17 and nine excluded women with multiple gestations (Table 1). 8–12,14,15,17–20 All but one 15 of the study reports specified that preeclampsia was defined using established criteria defined as a blood pressure ≥140/90 mmHg or a rise in systolic blood pressure >30 mmHg or diastolic blood pressure >15 mmHg after 20 weeks’ gestation, in addition to either ≥1+ dipstick proteinuria on two separate occasions, ≥2+ dipstick proteinuria on one occasion or ≥300 mg proteinuria over 24 hours. 21,22 None of the studies had masked and independent assessment of exposure and outcome.
The variation in prevalence of preeclampsia among studies is presumably related in part to the exclusion of women at high risk for preeclampsia, 9,12,17 or to geographic and ethnic differences between participants (Table 1). For example, one study included Asian women, 19 whereas others solely recruited women from North America. 8–15
A total of 1,390,226 women were included in the 13 studies. The BMI categories and corresponding percentages of preeclampsia are listed in Table 2. The risk of preeclampsia characteristically rose with increasing BMI, as did the unadjusted RR of preeclampsia (Figure 1). In most studies, there was a step-up increase in the unadjusted RR of preeclampsia with each increasing BMI category, which was most evident in the largest studies. 9,15,18,19 The risk of preeclampsia typically doubled for each 5 to 7 kg/m2 increase in BMI (Figure 1).
In those five studies that excluded women with chronic hypertension there appeared a nonsubstantial 12,17 or substantial 9,13,19 trend of increasing preeclampsia risk with rising prepregnancy BMI (Figure 1). Nonsubstantial 12,17 and substantial 9,19 trends were also seen in the four studies that excluded women with diabetes mellitus (Figure 1).
Eight studies used multivariate analysis to adjust for potential confounders, as listed in Table 3. Using those comparison and referent BMI categories set by the authors, all eight studies observed at least a doubling of the risk of preeclampsia with excess maternal BMI (Table 3).
Considering all 43 BMI categories from the 13 studies, and using the weighted mixed-effects linear model, the risk of preeclampsia typically rose by 0.54% (CI = 0.27–0.80) for each 1-kg/m2 increase in BMI (Figure 2).
In a systematic overview of 13 cohort studies we observed a consistent and linear rise in the risk of preeclampsia with increasing prepregnancy BMI.
Weaknesses and Strengths
We avoided deriving a pooled estimate of the RR of preeclampsia, principally because each study defined the BMI categories differently. Although we chose to plot the relation among the 43 BMI categories and the corresponding preeclampsia rates from all 13 studies (Figure 2), we did so knowing that the result should be interpreted with caution. Even so it might be useful as a research tool (see below). Our use of the mid-point value for each BMI category may have approximated the true mean BMI imprecisely within that category. For the lowest and highest BMI categories, we used values that were closest to the respective category cutoff values, likely leading to an overestimate of the true relation between BMI and preeclampsia. We further acknowledge that study publication bias, with the omission of negative studies, also might have led to an overestimate of the relation between prepregnancy BMI and preeclampsia.
The observed association between prepregnancy BMI and preeclampsia may be confounded by the presence of chronic hypertension, 23 diabetes mellitus 24 and other elements of the dysmetabolic syndrome, 5 each of which are known risk factors for preeclampsia. When we evaluated studies that either excluded women with chronic hypertension or diabetes mellitus, or that adjusted for the presence of these and other confounders, the relation between maternal BMI and preeclampsia usually remained unchanged. 9,13,19,20 Thus, it is likely that elevated BMI is an independent predictor of preeclampsia risk, just as for other adverse pregnancy events. 7
We considered only those studies that assessed prepregnancy BMI as a primary exposure. BMI is a better overall measure of obesity than weight alone. 23 Although seven 9,10,12,13,15–17 of the 13 cohort studies used self-reported prepregnancy height and weight for the calculation of BMI, this method reliably approximates measured BMI. 25
Mechanisms of Disease
There is likely more than one mechanism underlying the relation of prepregnancy obesity to preeclampsia. Placental vasculopathy and endothelial dysfunction appear central to the pathogenesis of preeclampsia. 1,3,26,27 Individuals with the dysmetabolic syndrome, of which obesity is a major feature, also exhibit chronic hypertriglyceridemia, a risk factor for endothelial dysfunction. 28 Hyperlipidemia may also alter prostaglandin regulation, leading to arteriolar constriction, 27 whereas biomarkers of insulin resistance, including plasminogen activator inhibitor, leptin and tumor necrosis factor, appear higher in women with preeclampsia. 29–31 Finally, obesity, a major risk factor for obstructive sleep apnea and associated hypertension, 32 is commonly found in pregnant women with disordered breathing during sleep. 33 Preeclamptic women with obstructive sleep apnea have higher blood pressure during obstructive periods. 34
We observed a continuous relation between prepregnancy BMI and the risk of preeclampsia. Further work could explore the interplay between BMI and other common risk factors for preeclampsia, including maternal age, gravidity and ethnicity. Taken together, these risk factors might enable better prediction of a woman’s risk of preeclampsia.
It is not known whether a program of lifestyle modification, including prepregnancy weight loss, can reduce the risk of preeclampsia. A randomized clinical trial might usefully evaluate this question among obese women of reproductive age. Both the exposure (ie, obesity) 35 and the outcome (ie, preeclampsia) 1 are common, and screening for obesity requires little time or special equipment. 36 Second, there are other potential benefits to prepregnancy weight loss, including lower risk of gestational diabetes mellitus, Cesarean delivery, and perinatal morbidity and mortality. 37 Moreover, obesity before pregnancy is a major predictor of obesity later in life, which is commonly associated with the development of chronic hypertension, dyslipidemia and type 2 diabetes mellitus. 38
Two randomized clinical trials among middle-aged obese adults with glucose intolerance clearly demonstrated that dietary modification, increased physical activity, and weight loss can be achieved, with a 50% reduction in subsequent type 2 diabetes mellitus. 39,40–42 Based on results of our linear models, prepregnancy weight reduction might produce an approximately 0.54% decrease in the rate of preeclampsia per 1-kg/m2 decline in BMI.
We thank Marian J. Vermeulen for her helpful comments about the data analyses.
The weighted mixed effects linear model may be written as:EQUATION
fixed effects random effects
where, BMI ij denotes i th body mass index measure within the j th study, Y ij is the rate of preeclampsia for the i th BMI measure within the j th study, γ00 is the overall intercept, γ10 is the overall slope, u0j is the variation between study intercepts, u1j is the variation between study slopes and rij is the random error associated. Cited Here...
1. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357: 53–56.
2. Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001; 357: 209–215.
3. Hayman R, Brockelsby J, Kenny L, Baker P. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Investig 1999; 6: 3–10.
4. Solomon CG, Seely EW. Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension 2001; 37: 232–239.
5. Barden AE, Beilin LJ, Ritchie J, Walters BN, Micheal C. Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? J Hypertens 1999; 17: 1307–1315.
6. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among U.S. adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.
7. Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998; 338: 147–152.
8. Edwards LE, Hellerstedt WL, Alton IR, Story M, Himes JH. Pregnancy complications and birth outcomes in obese and normal-weight women: effects of gestational weight change. Obstet Gynecol 1996; 87: 389–394.
9. Sibai BM, Ewell M, Levine RJ, et al
. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol 1997; 177: 1003–1010.
10. Ogunyemi D, Hullett S, Leeper J, Risk A. Prepregnancy body mass index, weight gain during pregnancy, and perinatal outcome in a rural Black population. J Matern Fetal Med 1998; 7: 190–193.
11. Bianco AT, Smilen SW, Davis Y, Lopez S, Lapinski R, Lockwood C. Pregnancy outcome and weight gain recommendations for the morbidly obese woman. Obstet Gynecol 1998; 91: 97–102.
12. Bowers D, Cohen W. Obesity and related pregnancy complications in an inner-city clinic. J Perinatol 1999; 19: 216–219.
13. Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet Gynecol 1999; 94: 543–550.
14. Steinfeld JD, Valentine S, Lerer T, Ingardia CJ, Wax JR, Curry JL. Obesity-related complications of pregnancy vary by race. J Matern Fetal Med 2000; 9: 238–241.
15. Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health 2001; 91: 436–440.
16. Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epiemiol 1998; 147: 1062–1070.
17. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective study. Obstet Gynecol 1998; 92: 174–178.
18. Conde-Agudelo A, Belizan J. Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. Br J Obstet Gynecol 2000; 107: 75–83.
19. Lee CJ, Hsieh TT, Chiu TH, Chen KC, Lo LM, Hung TH. Risk factors for pre-eclampsia in an Asian population. Int J Gynecol and Obstet 2000; 70: 327–333.
20. Sebire N, Jolly M, Harris JP, et al
. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes 2001; 25: 1175–1182.
21. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990; 163: 1689–1712.
22. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group of High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1–S22.
23. Ray JG, Burrows R, Burrows EA, Vermeulen M. MOS HIP: McMaster outcome study of hypertension in pregnancy 1 (MOS HIP 1). Early Hum Dev 2001; 64: 129–143.
24. Ray JG, Vermeulen MJ, Shapiro JL, Kenshole AB. Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. QJM 2001; 94: 347–356.
25. Willett W, Stampfer MJ, Lipnick BC, et al
. Cigarette smoking, relative weight and menopause. Am J Epidemiol 1983; 117: 651–658.
26. DeWolf F, Brosens I, Renaer M. Fetal growth retardation and the maternal arterial supply in the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980; 87: 678–685.
27. Roberts JM, Taylor RN, Goldfein A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome pre-eclampsia. Am J Hypertens 1991; 4: 700–708.
28. de Man FH, Weverling-Rijnsburger AW, van der Laarse A, Smelt AH, Jukema JW, Blauw GJ. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arterioscler Thromb Vasc Biol 2000; 20: 744–750.
29. McCarthy JF, Misra DN, Roberts JM. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol 1999; 180: 731–36.
30. Estelles A, Gilabert J, Grancha S et al. Abnormal expression of type 1 plasminogen activator and tissue factor in severe preeclampsia. Thromb Haemost 1998; 79: 500–8.
31. Vince GS, Startkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102: 20–5.
32. Berger HA, Somers VK, Phillips BG. Sleep disordered breathing and hypertension. Curr Opin Pulm Med 2001; 7: 386–90.
33. Maasilta P, Bachour A, Teramo K, Polo O, Laitinen LA. Sleep-related disordered breathing during pregnancy in obese women. Chest 2001; 120: 1448–1454.
34. Edwards N, Blyton DM, Kirjavainen TT, Sullivan CE. Hemodynamic responses to obstructive respiratory events during sleep are augmented in women with preeclampsia. Am J Hypertens 2001; 14: 1090–1095.
35. Solomon CG, Willett WC, Carey VJ, et al
. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997; 278: 1078–1083.
36. Kiernan M, Winkleby MA. Identifying patients for weight-loss treatment: an empirical evaluation of the NHLBI obesity education initiative expert panel treatment recommendations. Arch Intern Med 2000; 160: 2169–2176.
37. Lu GC, Rouse DJ, DuBard M, Cliver S, Kimberlin D, Harith JC. The effect of the increasing prevalence of maternal obesity on perinatal morbidity. Am J Obstet Gynecol 2001; 185: 845–849.
38. Brown CD, Higgins M, Donato KA, et al
. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000; 8: 605–619.
39. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–1350.
40. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403.
This article has been cited 145 time(s).
Journal of Obstetrics and Gynaecology ResearchRisk factors of early and late onset pre-eclampsiaJournal of Obstetrics and Gynaecology Research
Annals of Human BiologyImpact of risk factors on hypertensive disorders in pregnancy, in primiparae and multiparaeAnnals of Human Biology
ObesityModeling the Potential Public Health Impact of Prepregnancy Obesity on Adverse Fetal and Infant OutcomesObesity
Contemporary Clinical TrialsThe Maternal Obesity Management (MOM) Trial Protocol: A lifestyle intervention during pregnancy to minimize downstream obesityContemporary Clinical Trials
Plos MedicinePreeclampsia as a Risk Factor for Diabetes: A Population-Based Cohort StudyPlos Medicine
Journal of Clinical Endocrinology & MetabolismMaternal Obesity Is Associated With the Formation of Small Dense LDL and Hypoadiponectinemia in the Third TrimesterJournal of Clinical Endocrinology & Metabolism
Obesity SurgeryPregnancy Outcomes after Laparoscopic Sleeve Gastrectomy in Morbidly Obese Korean PatientsObesity Surgery
Stem Cells and DevelopmentHigh Aminopeptidase N/CD13 Levels Characterize Human Amniotic Mesenchymal Stem Cells and Drive Their Increased Adipogenic Potential in Obese WomenStem Cells and Development
American Journal of Obstetrics and GynecologyGestational weight gain as a risk factor for hypertensive disorders of pregnancyAmerican Journal of Obstetrics and Gynecology
American Journal of Obstetrics and GynecologyAdvanced lipoprotein measures and recurrent preterm birthAmerican Journal of Obstetrics and Gynecology
LancetMaternal and child undernutrition and overweight in low-income and middle-income countriesLancet
Journal of Maternal-Fetal & Neonatal MedicineInfluencing factors for late-onset preeclampsiaJournal of Maternal-Fetal & Neonatal Medicine
Gynecological EndocrinologyFemale obesity: short- and long-term consequences on the offspringGynecological Endocrinology
MidwiferyPatterns of gestational weight gain in healthy, low-risk pregnant women without co-morbiditiesMidwifery
Bmj OpenPre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort studyBmj Open
Preventive MedicineIs obesity still increasing among pregnant women? Prepregnancy obesity trends in 20 states, 2003-2009Preventive Medicine
ObesityRisk Factors and Outcomes of Maternal Obesity and Excessive Weight Gain During PregnancyObesity
American Journal of PerinatologyIs Obesity an Independent Barrier to Obtaining Prenatal Care?American Journal of Perinatology
Bjog-An International Journal of Obstetrics and GynaecologyChanges in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity HospitalBjog-An International Journal of Obstetrics and Gynaecology
American Journal of Physiology-Endocrinology and MetabolismIncreased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expressionAmerican Journal of Physiology-Endocrinology and Metabolism
Diabetes CareAbdominal Visceral Adiposity in the First Trimester Predicts Glucose Intolerance in Later PregnancyDiabetes Care
Bjog-An International Journal of Obstetrics and GynaecologyBrief overview of maternal triglycerides as a risk factor for pre-eclampsiaBjog-An International Journal of Obstetrics and Gynaecology
Hypertension in PregnancySerum adiponectin concentration prior to clinical onset of preeclampsiaHypertension in Pregnancy
Molecular Reproduction and DevelopmentImpaired cytotrophoblast cell-cell fusion is associated with reduced syncytin and increased apoptosis in patients with placental dysfunctionMolecular Reproduction and Development
Bjog-An International Journal of Obstetrics and GynaecologyHyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass indexBjog-An International Journal of Obstetrics and Gynaecology
Seminars in Fetal & Neonatal MedicineManagement of maternal obesity prior to and during pregnancySeminars in Fetal & Neonatal Medicine
Journal of Clinical Psychiatry
Pregnancy outcome of women using atypical antipsychotic drugs: A prospective comparative study
Journal of Clinical Psychiatry, 66(4):
Clinical ScienceBMI: new aspects of a classical risk factor for hypertensive disorders in pregnancyClinical Science
Journal of Womens Health
Pregnancy and obesity: A review and agenda for future research
Journal of Womens Health, 15(6):
Bjog-An International Journal of Obstetrics and GynaecologyObesity in pregnancyBjog-An International Journal of Obstetrics and Gynaecology
International Journal of Gynecology & ObstetricsReduced plasma adiponectin and elevated leptin in pre-eclampsiaInternational Journal of Gynecology & Obstetrics
Journal of Obstetrics and GynaecologyObesity and pregnancyJournal of Obstetrics and Gynaecology
Breast Cancer ResearchRisk of breast cancer among daughters of mothers with diabetes: a population-based cohort studyBreast Cancer Research
Ethnicity & Disease
The Effect of Language Preference on Prenatal Weight Gain and Postpartum Weight Retention in Urban Hispanic Women
Ethnicity & Disease, 20(2):
American Journal of TransplantationLetter to the EditorAmerican Journal of Transplantation
Seminars in Fetal & Neonatal MedicineSetting maternity care standards for women with obesity in pregnancySeminars in Fetal & Neonatal Medicine
Hypertension in PregnancyObesity and the Hypertensive Disorders of PregnancyHypertension in Pregnancy
Seminars in Fetal & Neonatal MedicineObesity in pregnancy: prevalence and metabolic consequencesSeminars in Fetal & Neonatal Medicine
Seminars in Fetal & Neonatal MedicineMaternal obesity: consequences for children, challenges for clinicians and carersSeminars in Fetal & Neonatal Medicine
International Journal of EpidemiologyCommentary: On the clinical prediction of pre-eclampsia and its enigmatic aetiologyInternational Journal of Epidemiology
Journal of Maternal-Fetal & Neonatal MedicineThe change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational ageJournal of Maternal-Fetal & Neonatal Medicine
Seminars in Fetal & Neonatal MedicineObesity, gestational diabetes and pregnancy outcomeSeminars in Fetal & Neonatal Medicine
Reproductive SciencesCirculating and Uteroplacental Adipocytokine Concentrations in PreeclampsiaReproductive Sciences
Molecular Human ReproductionIdentification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approachMolecular Human Reproduction
Bjog-An International Journal of Obstetrics and GynaecologyAccuracy of body mass index in predicting pre-eclampsia: bivariate meta-analysisBjog-An International Journal of Obstetrics and Gynaecology
Gynecologie Obstetrique & FertilitePregnancy in obese patients: which risks is it necessary to fear?Gynecologie Obstetrique & Fertilite
DiabetologeGender specific aspects in metabolic syndromeDiabetologe
Plos OneSevere Obesity in Young Women and Reproductive Health: The Danish National Birth CohortPlos One
American Journal of Obstetrics and GynecologyHyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsiaAmerican Journal of Obstetrics and Gynecology
European Journal of Obstetrics Gynecology and Reproductive BiologyPregnancy outcome in obese and morbidly obese gestational diabetic womenEuropean Journal of Obstetrics Gynecology and Reproductive Biology
Public Health Reports
Maternal obesity and risk of infant death based on Florida birth records for 2004
Public Health Reports, 123(4):
Journal of Maternal-Fetal & Neonatal MedicineMaternal BMI and preterm birth: A systematic review of the literature with meta-analysisJournal of Maternal-Fetal & Neonatal Medicine
Journal of Clinical EpidemiologySearching one or two databases was insufficient for meta-analysis of observational studiesJournal of Clinical Epidemiology
Birth Defects Research Part A-Clinical and Molecular TeratologyTeratology public affairs committee position paper: Maternal obesity and pregnancyBirth Defects Research Part A-Clinical and Molecular Teratology
Drug Development ResearchMetabolic syndrome and higher risk of maternal placental syndromes and cardiovascular diseaseDrug Development Research
Gynecologic and Obstetric InvestigationRisk indicators of pre-eclampsia in North Jordan: Is dental caries involved?Gynecologic and Obstetric Investigation
Trends in Molecular MedicineDoes the fetal genotype affect maternal physiology during pregnancy?Trends in Molecular Medicine
Cadernos De Saude Publica
Waist circumference in the prediction of obesity-related adverse pregnancy outcomes
Cadernos De Saude Publica, 23(2):
American Journal of Obstetrics and GynecologyAbnormal endothelium-dependent microvascular dilator reactivity in pregnancies complicated by normotensive intrauterine growth restrictionAmerican Journal of Obstetrics and Gynecology
American Journal of Obstetrics and GynecologyThe influence of obesity and diabetes on the prevalence of macrosomiaAmerican Journal of Obstetrics and Gynecology
Gynecologic and Obstetric InvestigationPlasma cell membrane glycoprotein-1 K121Q polymorphism in preeclampsiaGynecologic and Obstetric Investigation
Obstetrical & Gynecological Survey
Determination of maternal body composition in pregnancy and its relevance to perinatal outcomes
Obstetrical & Gynecological Survey, 59():
American Journal of Obstetrics and GynecologyMapping the theories of preeclampsia: The need for systematic reviews of mechanisms of the diseaseAmerican Journal of Obstetrics and Gynecology
Normal and high-normal blood pressures, but not body mass index, are risk factors for the subsequent occurrence of both preeclampsia and gestational hypertension: A retrospective cohort study
Hypertension Research, 29(3):
Occupational and Environmental MedicineRisk of prematurity, low birthweight and pre-eclampsia in relation to working hours and physical activities: a systematic reviewOccupational and Environmental Medicine
Paediatric and Perinatal EpidemiologyMortality of mothers from cardiovascular and non-cardiovascular causes following pregnancy complications in first deliveryPaediatric and Perinatal Epidemiology
Journal of Maternal-Fetal & Neonatal MedicineThe association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic womenJournal of Maternal-Fetal & Neonatal Medicine
Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study
American Journal of EpidemiologyInflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsiaAmerican Journal of Epidemiology
Diabetes CareATLANTIC DIP: The Impact of Obesity on Pregnancy Outcome in Glucose-Tolerant WomenDiabetes Care
Seminars in Fetal & Neonatal MedicineObesity in pregnancy: outcomes and economicsSeminars in Fetal & Neonatal Medicine
Annals of EpidemiologyThe risk of preeclampsia rises with increasing prepregnancy body mass indexAnnals of Epidemiology
Nutrition ReviewsNutrition and pregnancy outcomeNutrition Reviews
HypertensionShared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular diseaseHypertension
Arquivos Brasileiros De Cardiologia
Study on the major maternal risk factors in hypertensive syndromes
Arquivos Brasileiros De Cardiologia, 91(1):
HypertensionHypertensive Pregnancy Disorders and Subsequent Cardiovascular Morbidity and Type 2 Diabetes Mellitus in the MotherHypertension
Fertility and SterilityIs the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination?Fertility and Sterility
American Heart JournalCardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analysesAmerican Heart Journal
British Journal of NutritionCut-off points for anthropometric indices of adiposity: differential classification in a large population of young womenBritish Journal of Nutrition
Reproductive SciencesNeutrophil Infiltration and Systemic Vascular Inflammation in Obese WomenReproductive Sciences
Human Reproduction UpdateMaternal metabolism and obesity: modifiable determinants of pregnancy outcomeHuman Reproduction Update
Sao Paulo Medical Journal
Risk factors for cardiovascular disease ten years after preeclampsia
Sao Paulo Medical Journal, 128(1):
Response: Adiponectin concentrations in preeclampsia
Acta Obstetricia Et Gynecologica Scandinavica
Obesity and pregnancy
Acta Obstetricia Et Gynecologica Scandinavica, 83():
Adiponectin gene haplotype is associated with preeclampsia
Genetic Testing, 10(1):
Clinical and Experimental Pharmacology and PhysiologyPre-eclampsia: Contribution of maternal constitutional factors and the consequences for cardiovascular healthClinical and Experimental Pharmacology and Physiology
Archives of Gynecology and ObstetricsA new metabolic scoring system for analyzing the risk of hypertensive disorders of pregnancyArchives of Gynecology and Obstetrics
Atherosclerosis SupplementsDo pregnancy complications and CVD share common antecedents?Atherosclerosis Supplements
Mediators of InflammationVascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonatesMediators of Inflammation
PediatricsPerinatal circulating visfatin levels in intrauterine growth restrictionPediatrics
Diabetes CareUse of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetesDiabetes Care
British Medical JournalPrepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort studyBritish Medical Journal
Obesity ReviewsObesity as an independent risk factor for elective and emergency caesarean delivery in nulliparous women - systematic review and meta-analysis of cohort studiesObesity Reviews
Hypertension in PregnancyInteractions Between Inflammatory and Oxidative Stress in PreeclampsiaHypertension in Pregnancy
Obstetrics and Gynecology Clinics of North AmericaPregnancy and ObesityObstetrics and Gynecology Clinics of North America
American Journal of Obstetrics and GynecologyPrepregnancy body mass index, hypertensive disorders of pregnancy, and long-term maternal mortalityAmerican Journal of Obstetrics and Gynecology
American Journal of NephrologyNocturnal hypertension is associated with an exacerbation of the endothelial damage in preeclampsiaAmerican Journal of Nephrology
American Journal of Obstetrics and GynecologyLong-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndromeAmerican Journal of Obstetrics and Gynecology
Nutrition ReviewsRole of nutrition in the risk of preeclampsiaNutrition Reviews
Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome?
Diabetic Medicine, 23(3):
Annual Review of NutritionMaternal obesity, metabolism and pregnancy outcomesAnnual Review of Nutrition
Journal of Human HypertensionMaternal risk factors for hypertensive disorders in pregnancy: a multivariate approachJournal of Human Hypertension
Medical HypothesesHyperuricaemia and preeclampsia: is there a pathogenic link?Medical Hypotheses
American Journal of Obstetrics and GynecologyObstetric outcomes associated with increase in BMI category during pregnancyAmerican Journal of Obstetrics and Gynecology
American Journal of HypertensionDetermination of insulin resistance using the homeostatic model assessment (HOMA) and its relation with the risk of developing pregnancy-induced hypertensionAmerican Journal of Hypertension
Hypertension in PregnancyPopulation-based analysis of hypertensive disorders in pregnancyHypertension in Pregnancy
International Journal of EpidemiologyRisk of early or severe preeclampsia related to pre-existing conditionsInternational Journal of Epidemiology
Medical Journal of Australia
Effect of smoking among Indigenous and non-Indigenous mothers on preterm birth and full-term low birthweight
Medical Journal of Australia, 190(7):
Obstetrics and Gynecology Clinics of North AmericaPregnancy After Bariatric SurgeryObstetrics and Gynecology Clinics of North America
HypertensionPrevious hypertensive disease of pregnancy is associated with alterations of markers of insulin resistanceHypertension
Journal of Rheumatology
Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus
Journal of Rheumatology, 35(4):
Jama-Journal of the American Medical Association
Maternal Overweight and Obesity and the Risk of Congenital Anomalies A Systematic Review and Meta-analysis
Jama-Journal of the American Medical Association, 301(6):
American Journal of PerinatologyIncreased Preeclampsia in Mothers Delivering Very Low-Birth-Weight Infants between 1994 and 2006American Journal of Perinatology
Bjog-An International Journal of Obstetrics and GynaecologyBody composition by dual-energy X-ray absorptiometry in women with previous pre-eclampsia or small-for-gestational-age offspringBjog-An International Journal of Obstetrics and Gynaecology
HypertensionParadoxical elevation in adiponectin concentrations in women with preeclampsiaHypertension
Applied Physiology Nutrition and Metabolism-Physiologie Appliquee Nutrition Et MetabolismeExercise in the prevention and treatment of maternal-fetal disease: a review of the literatureApplied Physiology Nutrition and Metabolism-Physiologie Appliquee Nutrition Et Metabolisme
Bmc Public HealthEffect of Body Mass Index on pregnancy outcomes in nulliparous women delivering singleton babiesBmc Public Health
Australian & New Zealand Journal of Obstetrics & GynaecologyMaternal obesity and pregnancy complications: A reviewAustralian & New Zealand Journal of Obstetrics & Gynaecology
Acta Obstetricia Et Gynecologica ScandinavicaPrepregnancy weight status and the risk of adverse pregnancy outcomeActa Obstetricia Et Gynecologica Scandinavica
American Journal of Public HealthMaternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: A retrospective cohort studyAmerican Journal of Public Health
American Journal of EpidemiologyThe association of hypertensive disorders of pregnancy with weight gain over the subsequent 21 years: Findings from a prospective cohort studyAmerican Journal of Epidemiology
Nature Clinical Practice Endocrinology & MetabolismThe metabolic syndrome in womenNature Clinical Practice Endocrinology & Metabolism
Diabetes CarePrepregnancy diabetes and risk of placental vascular diseaseDiabetes Care
Trends in Endocrinology and MetabolismObesity: a risk factor for preeclampsiaTrends in Endocrinology and Metabolism
Journal of Perinatal MedicineAdiponectin in severe preeclampsiaJournal of Perinatal Medicine
West Indian Medical Journal
Obstetrical and neonatal outcomes in obese women
West Indian Medical Journal, 56(5):
Agro Food Industry Hi-Tech
The relationship between pregnancy and obesity: a call for further research
Agro Food Industry Hi-Tech, 18(1):
Journal of Adolescent HealthJoint Effect of Obesity and Teenage Pregnancy on the Risk of Preeclampsia: A Population-Based StudyJournal of Adolescent Health
DiabetologiaBody mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemiaDiabetologia
Journal of the Society for Gynecologic InvestigationAdiponectin concentrations in maternal serum: Elevated in preeclampsia but unrelated to insulin sensitivityJournal of the Society for Gynecologic Investigation
International Journal of ObesityBurden of disease attributable to obesity and overweight in KoreaInternational Journal of Obesity
International Journal of Gynecology & ObstetricsAssociation between delivery of a small-for-gestational-age neonate and long-term maternal cardiovascular morbidityInternational Journal of Gynecology & Obstetrics
Plos OneImpact of Obesity on Pregnancy Outcome in Different Ethnic Groups: Calculating Population Attributable FractionsPlos One
Obesity ReviewsMaternal adiposity as an independent risk factor for pre-eclampsia: a meta-analysis of prospective cohort studiesObesity Reviews
Acta Obstetricia Et Gynecologica ScandinavicaPregnancy after bariatric surgery - a review of benefits and risksActa Obstetricia Et Gynecologica Scandinavica
American Journal of Obstetrics and GynecologyGestational angiogenic biomarker patterns in high risk preeclampsia groupsAmerican Journal of Obstetrics and Gynecology
Clinical Obstetrics and GynecologyNutrition and PregnancyClinical Obstetrics and Gynecology
EpidemiologyBody Mass Index and PreeclampsiaEpidemiology
EpidemiologyTrends in Obesity in PregnancyEpidemiology
Obstetrics & GynecologyRecurring Complications in Second PregnancyObstetrics & Gynecology
Obstetrics & GynecologyGestational Weight Gain and Pregnancy Outcomes in Obese Women: How Much Is Enough?Obstetrics & Gynecology
body mass index; obesity; pregnancy; preeclampsia; toxemia; hypertension; cohort study; systematic overview
© 2003 Lippincott Williams & Wilkins, Inc.
What does "Remember me" mean?
By checking this box, you'll stay logged in until you logout. You'll get easier access to your articles, collections,
media, and all your other content, even if you close your browser or shut down your
To protect your most sensitive data and activities (like changing your password),
we'll ask you to re-enter your password when you access these services.
What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend
that you uncheck the "Remember me" box.
Highlight selected keywords in the article text.
Data is temporarily unavailable. Please try again soon.
Readers Of this Article Also Read